Skip to main content

Table 2 Comparison of general information between the two groups after propensity score matching

From: Effects of two different types of luteal support on pregnancy outcomes following antagonist fresh embryo transfer: a retrospective study

Parameter

VP

n = 1057

DYD + VP

n = 1057

P-value

Age, in years

  

0.06

 20–30

349 (33.02%)

323 (30.56%)

 

 31–35

414 (39.17%)

472 (44.65%)

 

 36–39

202 (19.11%)

170 (16.08%)

 

  ≥ 40

92 (8.70%)

92 (8.71%)

 

Type of infertility

  

0.19

 Primary infertility

660 (62.44%)

689 (65.18%)

 

 Secondary infertility

397 (37.56%)

368 (34.82%)

 

Years of infertility

  

0.50

  < 5 years

867 (82.02%)

886 (83.82%)

 

 5–10 years

162 (15.33%)

143 (13.53%)

 

  ≥ 10 years

28 (2.65%)

28 (2.65%)

 

BMI

22.31 (20.43, 24.97)

22.03 (20.05, 24.47)

0.03

Days of Gn medication

10 (9, 11)

10 (9, 11)

0.02

  1. BMI Body mass index, Gn gonadotropin, VP Vaginal progesterone gel group (single medication group), DYD + VP Dydrogesterone plus vaginal progesterone gel group (combination medication)